相关实验视频

Updated: May 19, 2025

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

GP73:解锁免疫疗法在固体瘤中的有效性的关键?

Rebecca J Bayliss¹, Alan L Parker²

¹Division of Cancer and Genetics, Cardiff University, Cardiff, UK BaylissR4@Cardiff.ac.uk.

Journal for immunotherapy of cancer

|May 13, 2025

概括

戈尔吉蛋白73 (GP73) 影响瘤中的T细胞功能. 恢复GP73增强T细胞杀死和瘤回归,表明其作为免疫疗法生物标志物和治疗点的潜力.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
分子生物学分子生物学

背景情况:

居民戈尔吉蛋白73 (GP73) 在病毒感染和癌症中被上调,作为coprotein.
GP73在瘤进展和免疫系统调节中起着至关重要的作用.
目前正在研究GP73在T细胞介导的抗瘤免疫中的功能,特别是在瘤微环境中.

研究的目的:

研究GP73在T细胞抗瘤免疫中的作用.
探索GP73对CD8+T细胞细胞毒性和低氧条件下的糖解的影响.
评估针对GP73进行癌症治疗和免疫治疗的治疗潜力.

主要方法:

利用了具有GP73缺乏T细胞的转基因小鼠模型.
分析了GP73与低氧诱导因子1α (HIF-1α) 和mTOR在低氧细胞中的相互作用.
评估了子宫外GP73表达对T细胞糖解和细胞毒性的影响.

主要成果:

缺少GP73会影响CD8+T细胞的细胞毒性和糖解.
GP73与HIF-1α和mTOR的相互作用对于低氧瘤环境中的T细胞功能至关重要.
宫外GP73表达恢复了T细胞糖解和细胞毒性,导致瘤回归.
GP73显示出作为预测免疫治疗反应的生物标志物的潜力.

结论:

GP73是T细胞细胞毒性在低氧瘤微环境中的关键调节者.
通过子宫外表达来向GP73提供了一种潜在的治疗策略,以增强抗瘤免疫力.
GP73可以作为指导免疫治疗临床治疗决策的有价值的生物标志物.

关键词:

生物标志物生物标志物免疫治疗是一种免疫疗法.一个T细胞细胞.瘤微环境 - - 瘤微环境

更多相关视频

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...